A novel multi-center study, serving as the largest pilot study for BRCA clinical testing in Nigeria to evaluate treatment & patient outcomes.

Study Outcomes

Feasibility of saliva based BRCA1/2 remote genetic testing

Evaluate the feasibility, acceptability, and cost-effectiveness

Patient reported outcome measures

Implement the Multidimensional Impact of Cancer Risk Assessment (MICRA) tool to measure the impact of result disclosure after genetic testing

Prevalence of BRCA1/2 mutation

Determine the proportion of BC patients with BRCA1/ BRCA2 mutations

Patient experience

Evaluate patient perceptions and experience post-surgery

Treatment related events

Review of type of surgery, treatment, and oncologic outcomes

100